Menu

Theranos Leaders Indicted For Fraud

Federal prosecutors filed criminal charges that allege the company’s promise to revolutionize blood testing swindled investors out of hundreds of millions of dollars and put patients in danger.

Jun 18, 2018
Ashley Yeager

ISTOCK, JASONDOLYElizabeth Holmes, founder and former CEO of the blood-testing company Theranos, and Ramesh Balwani, former president, have been indicted on charges of alleged fraud, The New York Times reported last Friday (June 15).

A grand jury filed criminal charges against Holmes and Balwani on two counts of conspiracy to commit wire fraud and nine counts of wire fraud in the indictment. The pair is accused of conning investors out of hundreds of millions of dollars, deceiving doctors and patients, and putting patients in personal danger. Holmes and Balwani could each spend up to 20 years in prison and be forced to pay $2.7 million in fines, according to STAT News.

Lawyers for Holmes did not respond to request for comment from The Times, but Balwani’s lawyer said in a statement that his client was “innocent and looks forward to clearing his name at trial.”

Theranos’s technology promised to use only a finger prick of blood to test for a range of conditions, including HIV or diabetics’ A1C levels. Holmes was so convinced that the technology would work that she would dog anyone who questioned it, The Times reports.

“This is someone who is so deeply self-deluded by her optimism and faith in herself,” technology consultant Paul Saffo tells The Times. “And delusion is contagious.”

Theranos announced in a statement that Holmes has stepped down as CEO, but she will remain chair of the board of the company.

 

February 2019

Big Storms Brewing

Can forests weather more major hurricanes?

Marketplace

Sponsored Product Updates

Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) today showcases new automation features of its ZE5 Cell Analyzer during the Society for Laboratory Automation and Screening 2019 International Conference and Exhibition (SLAS) in Washington, D.C., February 2–6. These capabilities enable the ZE5 to be used for high-throughput flow cytometry in biomarker discovery and phenotypic screening.
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Researchers to benefit from an innovative software-connected pipetting system, bringing improved reproducibility and traceability of experiments to life-science laboratories.
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Incorporated (NYSE: GLW) will showcase advanced 3D cell culture technologies and workflow solutions for spheroids, organoids, tissue models, and applications including ADME/toxicology at the Society for Laboratory Automation and Screening (SLAS) conference, Feb. 2-6 in Washington, D.C.
Corning Introduces New 1536-well Spheroid Microplate
Corning Introduces New 1536-well Spheroid Microplate
High-throughput spheroid microplate benefits cancer research, drug screening